ABOS
Acumen Pharmaceuticals Inc
2.70$
+2.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +506.8% | +418.4% | -14.6% | +57.8% | -22.9% | -48.6% | |
| – | +519.0% | +347.1% | -9.2% | +36.8% | -27.7% | -31.4% | |
| – | +568.1% | +179.1% | +6.5% | -48.6% | -46.7% | +51.5% | |
| – | +568.1% | +343.7% | -8.6% | +37.1% | -29.6% | -31.9% | |
| – | +263.3% | -100.1% | – | – | +76.9% | +57.0% | |
| – | +85.7% | -99.9% | +239,659.0% | -50.8% | +62.2% | – | |
| – | – | – | +358.3% | – | – | – | |
| – | – | – | – | – | -55.6% | -61.3% | |
| – | +236.3% | -91.8% | +51.8% | +452.4% | +32.5% | -8.3% | |
| – | +374.4% | -19.2% | +51.8% | +66.0% | +112.8% | +8.7% | |
| – | – | – | -24.5% | +724.8% | -84.6% | +6,603.0% | |
| – | +138.1% | +104.9% | +50.7% | -15.9% | +309.6% | -90.2% | |
| – | – | – | – | – | +4.1% | -21.3% | |
| – | – | – | -16.2% | +41.4% | -31.9% | -61.3% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +33.6% | +6.1% | +19.7% | +23.5% | +0.9% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.